FINWIRES · TerminalLIVE
FINWIRES

Pentair Stock Decline on Potential Inventory Destocking 'Overdone,' RBC Says

作者

-- Pentair (PNR) shares fell 10% following the company's Q1 earnings report on Tuesday but the sell off, tied to warnings of a potential inventory destocking, was "overdone," RBC Capital Markets said.

During the company's earnings call, Pentair disclosed expectations for its Pool channel partners to execute an inventory reduction in Q2 and Q3, which stems from a lowered industry volume forecast, especially for high-end discretionary products, the RBC analysts said. Pentair explained that recent price actions had prompted distributors to stock up, the analysts said.

The stock price decline was also driven by H2-weighted guidance and concerns over residential and consumer spending, according to the note.

However, Pentair continues its strong execution on productivity initiatives, margin improvement, and new product introductions, fueling a streak of 16 consecutive quarters of margin expansion, the analysts noted. They said that they have not observed any execution issues or missteps.

RBC maintained the company's stock rating at outperform and lowered the price target to $101 from $107.

Price: $81.36, Change: $-1.50, Percent Change: -1.81%

相关文章

Australia

瑞银表示,星巴克将保持销售增长势头,下半年将重点关注利润率。

瑞银周三在一份报告中指出,星巴克 (SBUX) 有望在其转型战略的推动下保持强劲的销售势头,但投资者关注的焦点正转向下半年的利润率复苏。 瑞银表示,第二季度强劲的交易驱动型同店销售增长反映了运营改善、菜单创新和更新的会员计划。 展望未来,瑞银表示,持续推进下午饮品平台、会员计划升级、门店关闭和运营改进等举措应能支撑下半年的销售增长。 瑞银还预计,在销售杠杆、成本节约以及关税和咖啡成本压力缓解的推动下,星巴克的利润率将在今年晚些时候有所提升。 瑞银将星巴克的目标股价从100美元上调至105美元,但维持“中性”评级。Price: $106.10, Change: $+8.82, Percent Change: +9.06%

$SBUX
Australia

美国银行证券上调评级后,Elevance Health股价上涨

周三,Elevance Health (ELV) 股价上涨 2.5%,此前美国银行证券将该股评级从“中性”上调至“买入”,目标价为 435 美元。 成交量约为 140 万股,低于日均 190 万股以上。Price: $371.74, Change: $+9.00, Percent Change: +2.48%

$ELV
Australia

Wedbush将Biogen的目标股价从191美元上调至196美元,理由是“催化引擎正在加速运转”,并维持中性评级。

根据FactSet调查的分析师报告,百健(BIIB)的平均评级为“增持”,平均目标价为213.79美元。 (报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们:https://www..com/contact-us)Price: $195.08, Change: $+11.70, Percent Change: +6.38%

$BIIB